March 09, 2017 article Open access A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer JAMA Oncology DOI: 10.1001/jamaoncol.2017.0013 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 5 stored of 775 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Personalizing neoadjuvant immune-checkpoint inhibition in patients with melanoma 2023 Nature Reviews Clinical Oncology review Medicine Cutaneous Melanoma Detection and Management 50 citations The impact of a pathologist’s personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer 2022 Lung Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 33 citations Development and validation of a supervised deep learning algorithm for automated whole‐slide programmed death‐ligand 1 tumour proportion score assessment in non‐small cell lung cancer 2021 Histopathology article Computer Science AI in cancer detection Open access 49 citations Programmed Death Receptor Ligand One Expression May Independently Predict Survival in Patients With Non-Small Cell Lung Carcinoma Brain Metastases Receiving Immunotherapy 2020 International Journal of Radiation Oncology*Biology*Physics article Medicine Cancer Immunotherapy and Biomarkers Open access 19 citations Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell Carcinoma 2020 Clinical Genitourinary Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 13 citations 5 results References 0